2019
DOI: 10.1007/s11255-019-02319-7
|View full text |Cite
|
Sign up to set email alerts
|

The impact of dyslipidemia and oxidative stress on vasoactive mediators in patients with renal dysfunction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(16 citation statements)
references
References 72 publications
0
15
0
Order By: Relevance
“…Dyslipidemia in MetS is a state with elevated level of plasma TG associated with increased level of very low-density lipoprotein (VLDL), small, dense LDL (sdLDL-C), FFAs and low HDL cholesterol level that promotes the development of atherosclerosis [113]. Indeed, oxidatively modified LDL (ox-LDL) is an important player in inducing the process of atherosclerosis as it affects expression of adhesive molecules, cytokines and growth factors and changes function of important vasoactive molecules such as NO, angiotensin II (Ang II) or endothelin 1 (ET 1) [114,115]. Interestingly, treatment of MetS patients with rosuvastatin causes beneficial effect not only on levels of ox-LDL, HDL, and inflammatory markers, but also ameliorates total antioxidant capability [116].…”
Section: Dyslipidemia and Oxidative Stressmentioning
confidence: 99%
“…Dyslipidemia in MetS is a state with elevated level of plasma TG associated with increased level of very low-density lipoprotein (VLDL), small, dense LDL (sdLDL-C), FFAs and low HDL cholesterol level that promotes the development of atherosclerosis [113]. Indeed, oxidatively modified LDL (ox-LDL) is an important player in inducing the process of atherosclerosis as it affects expression of adhesive molecules, cytokines and growth factors and changes function of important vasoactive molecules such as NO, angiotensin II (Ang II) or endothelin 1 (ET 1) [114,115]. Interestingly, treatment of MetS patients with rosuvastatin causes beneficial effect not only on levels of ox-LDL, HDL, and inflammatory markers, but also ameliorates total antioxidant capability [116].…”
Section: Dyslipidemia and Oxidative Stressmentioning
confidence: 99%
“…Additionally, the persistent hyperglycemia and hyperlipidemia are associated with elevation of ROS and reduction of antioxidant enzymes (35). Oxidative stress and dislipidemia result in chronic kidney disease and nephropathy (38). Thus in the present work, streptozotocinnicotinamide resulted in abnormalities in the liver and kidney functions.…”
Section: Discussionmentioning
confidence: 51%
“…The speculated theories pay significant attention to oxidative stress [23,24], understood as disturbances in the reactive oxygen species (ROS) production-degradation balance [25]. As such, this phenomenon is involved in the etiopathogenesis of numerous diseases, such as atherosclerosis, reduced kidney function, or ischemic stroke [26][27][28]. Recently, it is also considered to be one of the factors leading to the development of neurodegenerative and neuroinflammatory diseases of the central nervous system, e.g., multiple sclerosis, Alzheimer's disease, or Parkinson's disease [25,29,30].…”
Section: The Role Of Oxidative Stress In the Pathophysiology Of Migrainementioning
confidence: 99%